Company: FWDI
Filing Date: 2025-01-17
Form Type: 10-K/A
Source: 0001683168-25-000424
Chunk: 3

Company: Forward Industries, Inc.
Filing Date: 2025-01-17
Form: 10-K/A
Chunk 3
---
 of the Sarbanes-Oxley Act of 2002.

Except as described above, no other changes
have been made to the Original Form 10-K. The Original Form 10-K continues to speak as of the date of the Original Form 10-K, and
we have not updated the disclosure contained therein to reflect any events which occurred at a date subsequent to the filing of the Original
Form 10-K other than as expressly indicated in this Amendment.

| ii |

<div align='center'>PART III</div>

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS

The following table represents our Board of
Directors as of January 17, 2025:

| Name    | Age | Appointed |
| Sangita 
 Shah    |  58 | February  
 2015      |
| Sharon  
 Hrynkow |  64 | February  
 2022      |
| Terence 
 Wise    |  77 | February  
 2012      |

Director Biographies

Sangita Shah. Ms. Shah currently serves
as director and owner of Odyssean Enterprises Limited, a private advisory and investment company, in addition to serving as non-executive
chairman of Kinovo PLC, a leading UK provider of specialist property services centered on safety and regulatory compliance and non-executive
chairman of RA International PLC, a leading provider of services to remote locations in Africa and the Middle East. Ms. Shah is lead
director of Inspired PLC, UK's leading energy and sustainability advisor. Ms. Shah also serves as a board director of Quoted Companies
Alliance which represents over 90% of small and midsized market cap FTSE companies. Ms. Shah previously worked in seed/mezzanine financing
and strategic investments within the environmental and technology sectors following a number of senior roles held at KPMG and Ernst &
Young, Unilever and Mars. Ms. Shah was selected as a director for her board and accounting experience, and she also serves as our Lead
Director.

Sharon Hrynkow.Dr. Sharon Hrynkow
is Founder and President of Life Science Works, a professional services and consulting group dedicated to helping entrepreneurs
commercialize innovative technologies and secure non-dilutive funding, Prior roles include Chief Scientific Officer and Senior
VP for Medical Affairs at Cyclo Therapeutics (Nasdaq: CYTH) where she launched and led its drug development programs (2015 to 2022);
a range of senior